| Weathering the cytokine storm in susceptible patients with severe SARS-CoV-2 infection B Lipworth, R Chan, S Lipworth, CRW Kuo The Journal of Allergy and Clinical Immunology: In Practice 8 (6), 1798-1801, 2020 | 66 | 2020 |
| Pragmatic clinical perspective on biologics for severe refractory type 2 asthma R Chan, CRW Kuo, B Lipworth The Journal of Allergy and Clinical Immunology: In Practice 8 (10), 3363-3370, 2020 | 40 | 2020 |
| Targeting downstream type 2 cytokines or upstream epithelial alarmins for severe asthma R Chan, K Stewart, R Misirovs, BJ Lipworth The Journal of Allergy and Clinical Immunology: In Practice 10 (6), 1497-1505, 2022 | 39 | 2022 |
| Disconnect between effects of mepolizumab on severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps R Chan, CRW Kuo, B Lipworth The Journal of Allergy and Clinical Immunology: In Practice 8 (5), 1714-1716, 2020 | 35 | 2020 |
| The choice of biologics in patients with severe chronic rhinosinusitis with nasal polyps BJ Lipworth, R Chan The Journal of Allergy and Clinical Immunology: In Practice 9 (12), 4235-4238, 2021 | 24 | 2021 |
| 2020 updated asthma guidelines: clinical utility of fractional exhaled nitric oxide (Feno) in asthma management B Lipworth, CRW Kuo, R Chan Journal of Allergy and Clinical Immunology 146 (6), 1281-1282, 2020 | 23 | 2020 |
| Impact of nasal polyps on endotype and phenotype in patients with moderate to severe asthma R Chan, B Lipworth Annals of Allergy, Asthma & Immunology 127 (5), 548-552, 2021 | 21 | 2021 |
| Repeatability of impulse oscillometry in patients with severe asthma R Chan, R Misirovs, B Lipworth European Respiratory Journal 59 (1), 2022 | 19 | 2022 |
| Predicting severe outcomes in COVID-19 B Lipworth, R Chan, CR Kuo The Journal of Allergy and Clinical Immunology: In Practice 8 (8), 2582-2584, 2020 | 18 | 2020 |
| Forced vital capacity and low frequency reactance area measurements are associated with asthma control and exacerbations R Chan, B Lipworth Lung 200 (3), 301-303, 2022 | 17 | 2022 |
| Inhaled corticosteroids and COVID-19 B Lipworth, CRW Kuo, S Lipworth, R Chan American Journal of Respiratory and Critical Care Medicine 202 (6), 899-900, 2020 | 17 | 2020 |
| Impact of biologic therapy on the small airways asthma phenotype R Chan, BJ Lipworth Lung 200 (6), 691-696, 2022 | 16 | 2022 |
| Real-life small airway outcomes in severe asthma patients receiving biologic therapies R Chan, CRW Kuo, B Lipworth The Journal of Allergy and Clinical Immunology: In Practice 9 (7), 2907-2909, 2021 | 16 | 2021 |
| COVID-19: Start with the nose B Lipworth, R Chan, CRW Kuo Journal of Allergy and Clinical Immunology 146 (5), 1214, 2020 | 15 | 2020 |
| Impulse oscillometry bronchodilator response and asthma control CRW Kuo, R Chan, B Lipworth The Journal of Allergy and Clinical Immunology: In Practice 8 (10), 3610-3612, 2020 | 15 | 2020 |
| Anti-inflammatory reliever therapy for asthma B Lipworth, R Chan, CRW Kuo Annals of Allergy, Asthma & Immunology 124 (1), 13-15, 2020 | 15 | 2020 |
| Eosinophil depletion with benralizumab is associated with attenuated mannitol airway hyperresponsiveness in severe uncontrolled eosinophilic asthma R Chan, CRW Kuo, S Jabbal, BJ Lipworth Journal of Allergy and Clinical Immunology 151 (3), 700-705. e10, 2023 | 14 | 2023 |
| Combining low-frequency oscillometry and spirometry measurements in relation to asthma control and exacerbations in moderate-to-severe asthma R Chan, BJ Lipworth The Journal of Allergy and Clinical Immunology: In Practice 10 (7), 1910 …, 2022 | 14 | 2022 |
| Clinical associations of mucus plugging in moderate to severe asthma R Chan, C Duraikannu, B Lipworth The Journal of Allergy and Clinical Immunology: In Practice 11 (1), 195-199. e2, 2023 | 13 | 2023 |
| Determinants of asthma control and exacerbations in moderate to severe asthma R Chan, BJ Lipworth The Journal of Allergy and Clinical Immunology: In Practice 10 (10), 2758 …, 2022 | 12 | 2022 |
B J LipworthScottish Centre for Respiratory Research ,University of dundeeVerified email at dundee.ac.uk
